2004
Innovative Technology Could Represent New Frontier in Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the $6 million...
Indianapolis - As previously announced, Guidant Corporation (NYSE: GDT) will conduct a live webcast of its first quarter 2004 earnings conference call on Thursday, April 22 at 11:00 a.m. EDT. The...
World''s Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Bernard E. Kury will join Guidant as vice president and general counsel, effective April 12. Kury will report to Ronald W....
Reflects Strength Across Major Product Lines; Company Announces Live Webcast of its First Quarter Earnings Conference Call Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced...
Everolimus Eluting Stent Trial Will Provide Additional Safety and Performance Data Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first...
Important Milestone Achieved in Guidant''s Everolimus Eluting Stent Program; Next-Generation Drug Eluting Stent Utilizes Company''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind., and...
Results Will Broaden Patient Population Who Clearly Benefit from an Implantable Defibrillator Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Results Presented Today at American College of Cardiology Conference in New Orleans Indianapolis, Ind., and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Company Will Announce Final Results of Studies Evaluating New Stroke Prevention Technology at Late-Breaking Clinical Trials Session Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world...
INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that its board of directors has elected Jack A. Shaw, retired...
Agreement with Cordis, a Johnson & Johnson Company, Strengthens Guidant''s Broad Product Portfolio; Live Webcast Available Today at 9:00 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE:...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has entered into an agreement with Boston Scientific...
Company Announces Share Repurchase Program INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s...
Fourth quarter highlights: Worldwide implantable defibrillator revenue of $396 million, up 30 percent Worldwide stent revenue of $202 million, down 17 percent; up 2 percent versus third quarter...
Guidant Receives FDA Approval Based on COMPANION Clinical Trial Data Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Acquisition Positions Guidant to Enter New Therapy Area Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2003 earnings conference...
Self-Expanding Stent Features New, More Accurate Delivery System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Dean of Duke University''s Pratt School of Engineering Will Stand for Re-Election by Guidant Shareholders in May Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the...
Live Webcast Available INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the JPMorgan...